Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upstream regulators of RB have been involved in cancer initiation in patients, both in familial and sporadic cases, and in several organs and tissues25–27.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [26]
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P., & Wells, S. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.851 · Cited by 1,303
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Hofstra, R. M. W., Landsvater, R. M., Ceccherini, I., Stulp, R. P., Stelwagen, T., Luo, Y., Pasini, B., Hoppener, J. W. M., van Amstel, H. K. P., Romeo, G., et al. (1994) · Nature · doi:10.1038/367375a0 · Cited by 1,149
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Self-citationAnalysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 714
Research works printed but not linked: 1
- Walker, G.J. et al. .Mutations of the CDKN2/ p16INK4 gene in Australian melanoma kindreds. Hum. Molec. Genet. 4, 1845–1852 (1995).
Cited by
Items 701–800 of 817
The role of AIP and CDKN1B/p27Kip1 in endocrine neoplasia
Raitila, A. (2009) · Työväentutkimus Vuosikirja
MUTATIONS AND MOLECULAR SIGNATURES IN HUMAN MELANOMA
Jovanovic, B. (2010) · Figshare
The new melanoma: a novel model for disease progression
Schlegel, N. C. (2008) · ETH Zürich Research Collection · doi:10.3929/ethz-a-005593522
Molecular genetics of cutaneous malignant melanoma
Eskandarpour, M. (2007) · Figshare
Assessment of prognostic markers in benign and malignant melanocytic tumours
Svjatoha, V. (2011) · Figshare
The Biology and Genetics of Melanoma
Sharpless, N. E., & Chin, L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-994-3_15
Role of checkpoint kinase 1 in malignant melanoma
Smith, J. (2013) · Enlighten: Theses (The University of Glasgow)
Skin cancer in relation to tobacco use and organ transplantation
Odenbro, Å. (2009) · Figshare
Adam, N. M. (2006) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Assessment of therapeutic targets in experimental models of Myc-induced lymphoma
Forshell, L. P. (2011)
Chemoprevention of Familial Melanoma
Hariharan, V. (2011) · Loyola eCommons (Loyola University of Chicago)
Ouboussad, L. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Population-based family studies: Genetic contribution to cancer development and survival?
Lindström, L. S. (2008) · Figshare
Identification of Tumor Antigens Defined by Cytolytic T Lymphocytes and Therapeutic Implications
Wölfel, T. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7011-5_20
Inhibiting Cell Cycle Kinases in Cancer Therapy
de Cárcer, G., de Castro, I. P., & Malumbres, M. (2012) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608054640113060009 · Cited by 2
“family [226, 227]”
Cipponi, A. (2008) · DSpaceUnipr (University of Parma)
Lamarche, M. (2012) · eScholarship@McGill (McGill) · doi:10.82308/16187
"Analiza wariantów sekwencyjnych w odcinku 3'UTR genu CDKN2A u chorych na czerniaka".
Mackiewicz, A. A. (2011)
Leachman, S. A. (2006) · Elsevier eBooks · doi:10.1016/b978-84-8174-875-8.50021-4
Radiation, U. (2006)
Larsen, C. (2012) · Bulletin du Cancer · doi:10.1684/bdc.2012.1540
Molecular alterations in familial colorectal cancer
Hienonen, T. (2005) · Työväentutkimus Vuosikirja
Molekulargenetische Analyse des CDKN2A und des CDK4 Gens bei Patienten mit malignen Melanomen
Tübingen, A. D. U.-H., Dermatologie, A., Onkologie, S. F. D., & Garbe, C. (2006)
Familial Atypical Mole Melanoma (FAMM) Syndrome
Chao, E. D., Gabree, M., & Tsao, H. (2010) · Springer eBooks · doi:10.1007/978-0-387-93846-2_10
Renczyńska-Matysko, J., Imko‐Walczuk, B., & WOJNAROWSKA, F. T. (2011)
Koskivuo, I. (2008) · UTUPub (University of Turku)
Various functions of CDK inhibitor in skin.
Inohara, S. (1996) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.58.561
Deregulation of Cell Cycle Progression by Oncogenic Transformation
Rodríguez‐Puebla, M. L., Senderowicz, A. M., & Conti, C. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-313-2_8
Overview of Molecular Pathways in Melanoma
Fecher, L. A. (2008) · CRC Press eBooks · doi:10.3109/9781420020328.002
Activation of Oncogenic Protein Kinases
Martin, G. S. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50437-x
Imko‐Walczuk, B., Piesiaków, M., Okuniewska, A., & Traumatologii, C. (2012)
Susceptibility genes in hereditary breast cancer
Vahteristo, P. (2003) · Helda - University of Helsinki Institutional Repository
germline mutations in individuals with suspected genetic predisposition to uveal melanoma
Buecher, B., Gauthier‐Villars, M., Pauw, A. D., Tirapo, C., Houdayer, C., Stoppa‐Lyonnet, D., Desjardins, L., Rouïc, L. L.-L., Levy, R. C., Paillerets, B. B., et al. (2010)
Ayyıldız, Z. Ö. (2014) · Bilkent University Institutional Repository (Bilkent University)
Characterisation of the role of ING5
Basavarajaiah, P., & Lüscher, B. (2005) · RWTH Publications (RWTH Aachen)
Local IL-15-immunotherapy to treat melanoma
Hanes, M. R. (2017) · DalSpace (Dalhousie University)
Molecular Basis for Treating Cutaneous Melanoma
Ernstoff, M. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00042-1 · Cited by 1
Keuling, A. M. (2010) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3cq5d
(2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804000-3.00007-7
Molecular pathology of pancreatic cancer and premalignant tumors
Hechtman, J. F., & Iacobuzio–Donahue, C. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34062-5.00121-7
Molecular Epidemiology of Melanoma
Cust, A. E., Tsao, H., Berwick, M., Mann, G. J., & Iles, M. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-46029-1_48-1
Newton‐Bishop, J., & Jewell, R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00159-2
Paluncic, J. (2019) · The Sydney eScholarship Repository (The University of Sydney)
Prophylactic Surgical Procedures in Plastic Surgery
Dilek, Ö., Uslusoy, F., & Aydın, M. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-66853-2_29
Genotypic vs Phenotypic Risk Assessment for Melanoma
Sargen, M. R., & Tucker, M. A. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab077
Self-citationHereditary Cancers and Genetics
Fanale, D., Ottini, L., Ricevuto, E., Gristina, V., Calò, V., Incorvaia, L., Russo, A. D., Capoluongo, E., & Bazan, V. (2021) · UNIPA Springer series · doi:10.1007/978-3-030-56051-5_5 · Cited by 2
Siena, Á. D. D. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-04102021-152128
Disposition für erbliche Krebserkrankungen
Friedl, W., & Propping, P. (2009) · Springer eBooks · doi:10.1007/978-3-540-79725-8_5 · Cited by 1
Hodgson, S. V., Foulkes, W. D., Eng, C., & Maher, E. R. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2375-0_10
Rees, J. L. (2004) · Wiley eBooks · doi:10.1002/9780470750520.ch8
Hereditary Diseases That Implicate Defective Responses to DNA Damage
Friedberg, E. C., Walker, G. C., Siede, W., Wood, R. D., Schultz, R. A., & Ellenberger, T. E. (2014) · ASM Press eBooks · doi:10.1128/9781555816704.ch29
Self-citationSchneeberger, A., Strohal, R., & Stingl, G. (2004) · Springer eBooks · doi:10.1007/978-3-662-06670-6_65 · Cited by 1
Reifenberger, G., Kramm, C. M., Bilzer, T., & Kiwit, J. C. W. (1999) · Springer eBooks · doi:10.1007/978-3-662-07096-3_15
Bartsch, D. K., & Rothmund, Μ. (2001) · Springer eBooks · doi:10.1007/978-3-642-56889-3_15
Dong, J., & Chet, L. (2011) · InTech eBooks · doi:10.5772/18692
“Consistent with a tumor suppressor role of INK4A in melanomas, a germ line Arg24Cys (R24C) mutation in CDK4 has been identified in familial melanoma patients (Wolfel et al., 1995; Zuo et al., 1996).”
BackgroundO’Toole, E. A. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch11 · Cited by 1
Gupta, A. K., & Kirkwood, J. M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_15
Schomburg, I., Schomburg, P. D., & Chang, A. (2009) · Springer eBooks · doi:10.1007/978-3-540-85701-3_6
Rotte, A., & Bhandaru, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-48066-4_3
Molecular Epidemiology of Melanoma
Cust, A. E., Tsao, H., Berwick, M., Mann, G. J., & Iles, M. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-05070-2_48
Garbe, C., & Schittek, B. (2001) · Springer eBooks · doi:10.1007/978-3-642-56889-3_4
Inherited Contributions to Melanoma Risk
Brown, K. M., MacGregor, S., & Law, M. H. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_31
(2007) · Springer eBooks · doi:10.1007/978-3-540-49756-1_63
Disposition für erbliche Krebserkrankungen
Friedl, W., & Propping, P. (2004) · Springer eBooks · doi:10.1007/978-3-662-06670-6_5
American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology
(1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70121-0
Querem, G., & Dréno, B. (2009) · Springer eBooks · doi:10.1007/978-2-287-72092-5_16
Baker, S. J., & Reddy, E. P. (2017) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101949-1
de Snoo, F. A., & Hayward, N. K. (2004) · Informa Healthcare eBooks · doi:10.3109/9780203997352.159
Self-citationLange, J. R., Fecher, L. A., Sharfman, W. H., Alani, R. M., Mikkilineni, R., Topalian, S. L., & Balch, C. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50077-4 · Cited by 2
Baker, S. J., & Reddy, E. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101949
Melanomics: Comprehensive Molecular Analysis of Normal and Neoplastic Melanocytes
Nguyen, X. T. S., & Watson, I. R. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_30 · Cited by 2
Hesketh, R. (1997) · Elsevier eBooks · doi:10.1016/b978-012344548-3/50024-8
Bosenberg, M. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc009
Dubin, D. B., & Sarkar, S. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_85
Bastian, B. C., & Lazar, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-5649-2.00026-3 · Cited by 3
Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting beta cell differentiationPreprint
Stamateris, R. E., Sharma, R. B., Landa-Galván, H. V., Darko, C., Redmond, D., Rane, S. G., & Alonso, L. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.19.512511
Hendricks, W. P. D., Sekulić, A., Bryce, A. H., Murtaza, M., Ramos, P., Lang, J. D., Whitsett, T. G., McDaniel, T. K., Rockne, R. C., Banovich, N. E., et al. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm007.pub2
Eichler, M. (2023) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.74656
Grob, J., & Gaudy‐Marqueste, C. (2024) · Wiley eBooks · doi:10.1002/9781119709268.rook142 · Cited by 1
Gallas, L. F., Pacca, A. M., & Natal, R. D. A. (2024) · Surgical and Experimental Pathology · doi:10.1186/s42047-024-00168-y
Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics
Brizuela, L., Gyuris, J., & Mansuri, M. M. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-222-7_8 · Cited by 2
Effect of Grapes and Grape Constituents on UV-Induced Skin Damage in Humans
Koomoa, D. T., Piya, S., Pezzuto, J. M., & Lange, I. (2025) · Springer eBooks · doi:10.1007/978-3-031-96913-3_7
Molecular biology of pancreatic carcinoma
Yeung, R. S. W. (1998) · Cancer treatment and research · doi:10.1007/978-1-4615-4977-2_12
Antibody-based profiling of expression patterns using cell and tissue microarrays.
Strömberg, S. (2008) · DiVA (Digitala Vetenskapliga Arkivet)
Molecular Genetic Studies of Sporadic and MEN1-Associated Endocrine Pancreatic Tumors
Lindberg, D. M. (2007) · Uppsala University Publications (Uppsala University)
Nilsson, L. M. (2007) · DiVA at Umeå University (Umeå University)
Wang, W., Rickett, R., Teertam, S., Gunasekaran, S., & Setaluri, V. (2025) · Journal of Dermato-Oncology · doi:10.1080/29944376.2025.2578127
Marqueurs prédictifs de réponse aux inhibiteurs de BRAF dans le mélanome cutané métastatique
Funck-Brentano, E. (2016) · theses.fr (ABES) · doi:10.70675/73a2af67z6d03z483czb461zb0527aec1a30
Malka-Mahieu, H. (2015) · theses.fr (ABES) · doi:10.70675/0885c423zadabz4b67zad92zc16c642a3d08
Epigenetic regulation of gene expression during melanocyte and melanoma development
Laurette, P. (2016) · theses.fr (ABES) · doi:10.70675/b22b69c4z85a0z409czaccczc882ea46e923
Tisserand, J. C. (2016) · theses.fr (ABES) · doi:10.70675/75c7849fz8b54z4676zbd10z2a0e877439d8
Rôle pro-tumorigénique de HACE1 dans le mélanome
Hachem, N. E. (2017) · theses.fr (ABES) · doi:10.70675/c29467dezf843z4a4cz91a8z8b39a51c97c6
Rodrigues, M. J. (2018) · theses.fr (ABES) · doi:10.70675/5324f18az84f8z46d5z8365zd1bc1666321d
Déficience intellectuelle : identification de nouveaux gènes par une approche multicentrique
Piard, J. (2018) · theses.fr (ABES) · doi:10.70675/4983b815za289z44b8z908dz7ed0ab3f8736
Impact of Targeting the Autophagy Related Gene Beclin 1 on the Immune Landscape of Melanoma
Arakelian, T. (2018) · theses.fr (ABES) · doi:10.70675/cd5f1ed6z9100z4dd3zb7fazb0537054f400 · Cited by 1
Metadata
- Authors
- Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C.
- Affiliations
- National Institutes of Health (US)
- QIMR Berghofer Medical Research Institute (AU)
- Venue
- Nature Genetics
- Published
- 1996-01
- Volume
- 12
- Issue
- 1
- Pages
- 97-99
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2051506850
- Cited by
- 818
- References
- 29
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 11 · 2023: 13 · 2022: 13 · 2021: 19 · 2020: 19 · 2019: 23 · 2018: 24 · 2017: 36 · 2016: 24 · 2015: 27 · 2014: 32 · 2013: 30 · 2012: 19
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Keywords
- CDK4, germline mutations, familial melanoma, cyclin-dependent kinases, cyclin D, retinoblastoma protein phosphorylation, G1 cell cycle checkpoint, hereditary melanoma, tumor-specific antigens
- MeSH terms
- Base Sequence, Carrier Proteins, Female, Humans, Male, Melanoma, Molecular Sequence Data, Pedigree, Proto-Oncogene Proteins, DNA Primers, Polymorphism, Single-Stranded Conformational, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Cyclin-Dependent Kinase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.